Malaria wonder drug loses its grip

The global fight against malaria is being threatened by growing resistance to powerful new drugs that were ­considered one of the most ­important weapons in the battle.

Experts say the medical effects of artemisinin-based compounds, being used to treat people around the Burma-Thailand border, are weakening. Where there were once apparently miraculous recoveries of children treated with artemisinin combination therapy, now the treatments take longer to be effective. Doctors envisage a time when, if nothing is done, the drugs will cease to work.

Malaria-parasite resistance to the drugs has been identified in western Cambodia, but it was hoped tough controls would contain it. Now ­scientists say there are real problems in Burma and warn that resistance there must be tackled if it is not to spread worldwide.

They warn that history is repeating itself: resistance is appearing and artemisinin is losing its potency, just as happened with older drugs such as chloroquine, and it is beginning in the same places.

Resistance threatens malaria intiatives
The discovery of resistance to the drugs — which have, with insecticide-impregnated bed nets, altered the course of the malaria epidemic — “threatens worldwide initiatives to control and eliminate malaria”, reports a paper in the Lancet.

The paper is one of two by teams of scientists who have studied the growth of resistance on the Thai-Burmese border.

“Resistance to the previous mainstays of antimalarial treatment, namely, chloroquine and sulfadoxine-pyrimethamine, also arose in western Cambodia and spread across southeast Asia into Africa, resulting in the deaths of millions of children,” it said.

In the other paper, published in the journal Science, scientists in southeast Asia and the United States identified a major region of the malaria parasite genome associated with artemisinin resistance. This link could allow researchers to map resistance and help to prevent its spread.

Nick White, chair of the Worldwide Antimalarial Resistance Network and an author of each of the papers, said there were rumours that resistance might have spread to Burma. Said White, a professor who is also chair of the Wellcome Trust’s southeast Asia major overseas programmes: “There is no doubt there has been quite significant reduction in susceptibility to artemisinin. The problem is once it gets to Burma, because it is the gateway to the West. Malaria control in Burma is much weaker than in the rest of the region. It is going to be much more difficult to contain it.”

Because of the political situation, Burma did not get the same levels of funding for malaria control as other countries.

Misuse of the drugs in Asia has allowed parasitic resistance to develop and the sale of single artemisinin pills, which should be taken in combination with other drugs, has been a disaster. “It is pretty clear that the widespread availability of substandard counterfeit drugs and monotherapies is what has driven this,” White said.

He said more information on the spread of resistance was vital. If this was a flu pandemic, the West would be mobilising all its forces, but too little was being done despite the consequences.

“Is the response appropriate to the threat? I don’t think so. We really need to scale up. It is going to require an international effort.” —


Mabuza’s ‘distant relative’ scored big

Eskom’s woes are often because of boiler problems at its power plants. R50-billion has been set aside to fix them, but some of the contracts are going to questionable entities

ANC faction gunning for Gordhan

The ambush will take place at an NEC meeting about Eskom. But the real target is Cyril Ramaphosa

Despite tweet, Zuma keeps silent about providing his taxpayer information

The Public Protector has still not received confirmation from former president Jacob Zuma that she may access his tax records —...

Ahead of WEF, Mboweni will have to assure investors that...

The finance minister says despite the difficult fiscal environment, structural reforms are under way to put SA on a new growth path

Press Releases

New-style star accretion bursts dazzle astronomers

Associate Professor James O Chibueze and Dr SP van den Heever are part of an international team of astronomers studying the G358-MM1 high-mass protostar.

2020 risk outlook: Use GRC to build resilience

GRC activities can be used profitably to develop an integrated risk picture and response, says ContinuitySA.

MTN voted best mobile network

An independent report found MTN to be the best mobile network in SA in the fourth quarter of 2019.

Is your tertiary institution is accredited?

Rosebank College is an educational brand of The Independent Institute of Education, which is registered with the Department of Higher Education and Training.

Is your tertiary institution accredited?

Rosebank College is an educational brand of The Independent Institute of Education, which is registered with the Department of Higher Education and Training.

VUT chancellor, Dr Xolani Mkhwanazi, dies

The university conferred the degree of Doctor of Science Honoris Causa on Dr Xolani Mkhwanazi for his outstanding leadership contributions to maths and science education development.

Innovate4AMR now in second year

SA's Team pill-Alert aims to tackle antimicrobial resistance by implementing their strategic intervention that ensures patients comply with treatment.

Medical students present solution in Geneva

Kapil Narain and Mohamed Hoosen Suleman were selected to present their strategic intervention to tackle antimicrobial resistance to an international panel of experts.